Stay updated on PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a minor maintenance update to the page version. No study content or data were changed.SummaryDifference0.0%

- Check24 days agoChange DetectedA new publication citation has been added to the Publications section. It references a Nat Commun 2026 article on Copanlisib and Nivolumab in MSS colorectal cancer, expanding the study's bibliographic references.SummaryDifference0.0%

- Check31 days agoChange DetectedThe page revision was updated to v3.6.4, replacing the previous v3.6.3. This reflects an update to the page's revision metadata rather than changes to study data.SummaryDifference0.0%

- Check53 days agoChange DetectedThe revision tag on the page was updated from v3.6.2 to v3.6.3, signaling a newer version of the page template or backend update. This change does not modify study content, eligibility criteria, or results.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision: v3.6.2 was added to replace the previous v3.6.0 in the page footer, signaling a new version of the page. This likely reflects minor updates to content or formatting rather than substantive changes to the study information.SummaryDifference0.0%

- Check74 days agoChange DetectedThe study record now displays 'No longer looking for participants', indicating recruitment has closed. New navigational/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading was reformatted from 'Intervention / Treatment' to 'Intervention/Treatment'.SummaryDifference0.4%

Stay in the know with updates to PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial page.